Denali Advisors’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-57,500
| Closed | -$593K | – | 482 |
|
|
2023
Q4 | $593K | Buy |
+57,500
| New | +$593K | 0.18% | 122 |
|
|
2023
Q1 | – | Sell |
-5,900
| Closed | -$64.8K | – | 478 |
|
|
2022
Q4 | $64.8K | Buy |
5,900
+2,300
| +64% | +$25.3K | 0.03% | 199 |
|
|
2022
Q3 | $47K | Buy |
+3,600
| New | +$47K | 0.02% | 218 |
|